Sandoz Group AG | WebDisclosure

Basculer en Français

10456	Companies
219587	Keywords
148969	Articles
116111	Press releases

Home
Companies
Sandoz Group AG

PRESS RELEASE

published on 11/17/2025 at 07:00, 6 months 9 days ago

Sandoz launches TYRUKO® (natalizumab-sztn) in US, as first and only multiple sclerosis biosimilar
Sandoz launches TYRUKO® (natalizumab-sztn) in US, the first and only multiple sclerosis biosimilar, offering cost-effective treatment. TYRUKO® approved for all indications of reference medicine Tysabri®

US Market Multiple Sclerosis Biosimilar Sandoz TYRUKO
BRIEF

published on 11/12/2025 at 07:40, 6 months 14 days ago

Sandoz obtient une licence mondiale pour un biosimilaire du cancer du sein

Oncologie Biosimilaire Cancer Du Sein Sandoz Pertuzumab
BRIEF

published on 11/12/2025 at 07:40, 6 months 14 days ago

Sandoz Secures Global License for Breast Cancer Biosimilar

Oncology Biosimilar Breast Cancer Sandoz Pertuzumab
PRESS RELEASE

published on 11/12/2025 at 07:35, 6 months 14 days ago

Sandoz signs global license agreement to commercialize breast cancer biosimilar pertuzumab
Sandoz signs global license agreement with EirGenix Inc. to commercialize biosimilar pertuzumab for HER2-positive breast cancer treatment, reinforcing its position in oncology

Agreement Biosimilar Breast Cancer Sandoz Pertuzumab
BRIEF

published on 11/04/2025 at 22:10, 6 months 21 days ago

Sandoz acquiert Just-Evotec Biologics pour développer ses capacités dans le domaine des biosimilaires.

Acquisition Biosimilaires Toulouse Sandoz Just-Evotec
BRIEF

published on 11/04/2025 at 22:10, 6 months 21 days ago

Sandoz Acquires Just-Evotec Biologics to Expand Biosimilars Capabilities

Acquisition Biosimilars Toulouse Sandoz Just-Evotec
PRESS RELEASE

published on 11/04/2025 at 22:05, 6 months 21 days ago

Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees

Acquisition Biosimilars Sandoz Just-Evotec Biologics Continuous Manufacturing Technology
BRIEF

published on 10/30/2025 at 07:05, 6 months 27 days ago

Sandoz annonce une croissance de ses ventes et une révision à la hausse de ses prévisions de marge.

Croissance Des Ventes Biosimilaires Performance Régionale Orientation Financière Questions Commerciales
BRIEF

published on 10/30/2025 at 07:05, 6 months 27 days ago

Sandoz Reports Growth in Sales and Upgraded Margin Guidance

Financial Guidance Sales Growth Biosimilars Regional Performance Trade Issues
PRESS RELEASE

published on 10/30/2025 at 07:00, 6 months 27 days ago

Sandoz delivers a further acceleration in sales growth; full-year margin guidance upgraded
Sandoz reports 5% growth in net sales for 9 months, with biosimilars contributing over 30%. Full-year margin guidance raised to 21-22% core EBITDA

EBITDA Net Sales Biosimilars Sandoz Margin Guidance

Accesswire

Published on 05/26/2026 at 14:30, 2 hours 12 minutes ago

Klondike Gold Announces 2026 Diamond Drilling Program Underway to Update and Expand Gold Mineral Resources
Published on 05/26/2026 at 14:30, 2 hours 12 minutes ago

Predictiv AI Announces Strategic Healthcare Partnership and CloudRep AI Integration with Clinicmaster Following Successful Multi-Clinic Pilot Deployments
Published on 05/26/2026 at 14:30, 2 hours 12 minutes ago

In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides
Published on 05/26/2026 at 14:15, 2 hours 27 minutes ago

Worksport (NASDAQ:WKSP) Secures U.S. Patent For 'Industry-First' Zerofrost Heat Pump Through Its Subsidiary, Terravis Energy
Published on 05/26/2026 at 14:00, 2 hours 42 minutes ago

Ameriwest Critical Metals Provides Q2 2026 Corporate Update and Announces Live CEO Investor Webinar

View all ACCESSWIRE

EQS Group

Published on 05/26/2026 at 16:30, 11 minutes ago

M1 Kliniken AG: Capital reduction through cancellation of treasury shares successfully completed
Published on 05/26/2026 at 16:15, 27 minutes ago

R. STAHL AG Management Board member Dr. Claus Bischoff resigns from his office as Management Board member at his own request and for personal reasons and will leave by mutual agreement as of 31 May 20
Published on 05/26/2026 at 16:03, 39 minutes ago

EQS-Adhoc: R. Stahl AG: Dr. Claus Bischoff resigns from his office as member of the Management Board of R. STAHL Aktiengesellschaft with immediate effect and will leave the company as of 31 May 2026.
Published on 05/26/2026 at 16:01, 41 minutes ago

EQS-Adhoc: Tempton Personaldienstleistungen GmbH announces full redemption of bonds and the exercise of the early redemption option
Published on 05/26/2026 at 15:37, 1 hour 5 minutes ago

FGC plans regional rail transport in Catalonia with IVU.rail

Les Echos

Published on 05/26/2026 at 15:00, 1 hour 42 minutes ago

Besluiten Gewone en Buitengewone Algemene Vergaderingen
Published on 05/26/2026 at 15:00, 1 hour 42 minutes ago

Resolutions Ordinary and Extraordinary General Meetings
Published on 05/26/2026 at 07:59, 8 hours 43 minutes ago

Saint-Gobain signe un accord de cession de son activité de distribution de carrelage dans les pays nordiques
Published on 05/26/2026 at 07:59, 8 hours 43 minutes ago

Saint-Gobain has signed an agreement for the sale of its Tiles Distribution business in the Nordics
Published on 05/25/2026 at 18:00, 22 hours 42 minutes ago

Déclaration des transactions sur actions propres réalisées du 18/05/2026 au 24/05/2026

View all LES ECHOS COMFI WIRE